Targeting Drug-Tolerant Persister Cancer Cells: Can Nanomaterial-Based Strategies Be Helpful for Anti-DTP Therapies?

Ghoderao P, Kwiatkowska-Borowczyk E, Sahare S, Dams-Kozlowska H

Open source

DOI
10.3390/pharmaceutics17111428
Published
2025 Nov 4
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics17111428,
  title = {Targeting Drug-Tolerant Persister Cancer Cells: Can Nanomaterial-Based Strategies Be Helpful for Anti-DTP Therapies?},
  author = {Ghoderao P and Kwiatkowska-Borowczyk E and Sahare S and Dams-Kozlowska H},
  year = {2025},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics17111428},
  url = {https://doi.org/10.3390/pharmaceutics17111428}
}

RIS

TY  - JOUR
TI  - Targeting Drug-Tolerant Persister Cancer Cells: Can Nanomaterial-Based Strategies Be Helpful for Anti-DTP Therapies?
AU  - Ghoderao P
AU  - Kwiatkowska-Borowczyk E
AU  - Sahare S
AU  - Dams-Kozlowska H
PY  - 2025
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics17111428
UR  - https://doi.org/10.3390/pharmaceutics17111428
ER  - 

APA

P, G., E, K., S, S., & H, D. (2025). Targeting Drug-Tolerant Persister Cancer Cells: Can Nanomaterial-Based Strategies Be Helpful for Anti-DTP Therapies?. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17111428

Source records